Kyrgyzstan Medical Device Registration: Applicant, Authorized Representative and Importer Roles

1. Key takeaways

Device market access in Kyrgyzstan involves three legal roles: the applicant (the person who submits the registration application to the authorized body), the authorized representative of the manufacturer (a legal entity or individual entrepreneur that must be a resident of the Kyrgyz Republic, authorized under a power of attorney from the manufacturer to act on its behalf and to bear responsibility), and the importer (the entity that handles import for registration and assessment purposes). One organization may perform all three roles, but legally they are three distinct identities with different sources of obligations. A foreign manufacturer can land in this market only through the latter two roles; it cannot submit an application itself.

2. Legal basis

1. Cabinet Resolution No. 513 of August 27, 2024, Article 2 of Annex 1: the applicant is the person who submits an application for state registration of a medical device or for changes to the registration dossier to the authorized body.
2. Article 2 of Annex 1 to Cabinet Resolution No. 513: the authorized representative of the manufacturer is a legal entity registered in the Kyrgyz Republic, or a natural person registered as an individual entrepreneur, that is a resident of the Kyrgyz Republic, authorized under a power of attorney from the manufacturer of the medical device to act on its behalf and to bear responsibility for the circulation of the medical device and for compliance with mandatory requirements imposed on it.
3. Article 14 of Law No. 216: when device data and information change, the reporting obligation falls on the manufacturer or its authorized representative.
4. Article 30 of Law No. 216: the holder of a foreign registration certificate, the representative office of the manufacturer, or an entrusted person may handle import for registration and assessment purposes.
5. Article 3 of Annex 1 to Cabinet Resolution No. 513: registration is carried out by a subordinate unit of the authorized state body.

3. Expert insights

Insight 1: the statutory definition of the authorized representative contains four qualifying conditions, and none of them can be dropped.

Read Article 2 of Annex 1 to Resolution No. 513 word by word:

① Form of entity — a legal entity, or a natural person registered as an individual entrepreneur;

② Residency — must be a resident of the Kyrgyz Republic;

③ Source of authority — a power of attorney from the manufacturer;

④ Content of responsibility — acting on behalf of the manufacturer and bearing responsibility.

The first two are eligibility thresholds, the third is the source of power, and the fourth is the key. Bearing responsibility (нести ответственность) means that the authorized representative is not a mailing address but a responsibility node — the compliance consequences of device circulation and the execution of mandatory requirements legally fall on it. This is why, in Article 31 of this series, we stress that the selection criterion for an authorized representative is not its quotation but its capacity to bear responsibility.

Insight 2: the applicant and the authorized representative are not the same and can be separated.

The definition of the applicant retains only the formal element of submitting the application, with no residency requirement. In practice, however, a foreign manufacturer cannot hold the electronic system account itself (see Article 02 of this series) and cannot handle Russian-language submissions and on-site communication on its own, so the applicant role is in fact performed by the authorized representative. We recommend stating expressly in the agreement whether the applicant role is exercised by the representative in its own name or in the name of the manufacturer, so that the certificate holder named on the registration certificate does not contradict the internal arrangement (see Article 33 of this series for details).

Insight 3: the importer role is named by the law already at the registration stage.

Article 30 of Law No. 216 lists the holder of a foreign registration certificate, the representative office of the manufacturer, or an entrusted person as entities that may handle import for registration and assessment purposes. The value of this provision is that it answers the question of how samples can enter the country before registration is approved: importing unregistered devices for registration purposes is an import scenario expressly permitted by law (see Article 37 of this series). Samples imported for clinical trials or registration testing follow exactly this channel.

Insight 4: when all three roles are stacked on one organization, the concentration of risk is highest.

A local distributor acting simultaneously as authorized representative, applicant and importer is the most common arrangement in the market. It is the most efficient, but also the most concentrated in risk: if the cooperation ends, the registration certificate, the system account, the import channel and the post-market obligations all break at once. We recommend designing exit and migration clauses in advance, specifying dossier ownership, account handover, and the time limits and cost allocation for changing the registration certificate.

4. Practical recommendations

First, the authorized representative agreement must contain two major blocks: responsibility clauses and exit clauses. Responsibility clauses cover registration, import, post-market surveillance and vigilance, and cooperation with inspections; exit clauses cover the return of materials, account handover, cooperation in changing the registration certificate, and transitional arrangements. Missing either block is the most frequent risk we see in this market.

Second, the power of attorney must define the scope of authority item by item rather than granting blanket authorization. We recommend listing each item: submitting registration applications, signing documents, receiving official correspondence, handling changes and revocations, cooperating with inspections, handling import, and performing post-market obligations. A scope that is too narrow blocks the process; one that is too broad is impossible to control.

Third, for sample imports for registration purposes, prepare the statement of use in advance. Article 30 permits import for registration and assessment purposes, but the declaration must state the use, the quantity and the disposition of the samples (consumed in testing, retained as samples, or re-exported). Confirm the declaration approach with the authorized representative before shipment.

Fourth, fix the responsible party for post-market obligations in the agreement. Article 14 places the reporting obligation for data changes on the manufacturer or its authorized representative. If the agreement does not say who actually performs it, both parties will blame each other when a report is missed, and the competent authority will only look at what is recorded on the registration certificate.

5. Verification checklist

• □ Confirm that the authorized representative satisfies the four statutory conditions: legal entity or individual entrepreneur, resident of the Kyrgyz Republic, holding a power of attorney from the manufacturer, and bearing responsibility;
• □ The authorized representative agreement contains responsibility clauses and exit or migration clauses;
• □ The power of attorney lists the scope of authority item by item, consistent with the application form and the system account permissions;
• □ The manner in which the registration certificate holder is recorded has been decided and matches the internal arrangement;
• □ The statement of use for sample imports for registration and assessment purposes has been prepared (use, quantity, disposition);
• □ The party actually performing post-market surveillance and vigilance obligations has been specified in the agreement.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, production site inspection coordination, quality management system conformity support, post-market surveillance and device vigilance system setup, import and distribution compliance, official fee calculation and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations. We maintain a stable local cooperation network in Bishkek, Almaty, Tashkent and Moscow, work in Chinese, Russian and English, and provide executable solutions for the issues foreign manufacturers most often encounter in CIS markets, including authorized representative arrangements, the notarization and legalization chain for powers of attorney, localization of technical documentation, and inspection readiness.

We adhere to one principle: every regulatory conclusion we publish must rest on verifiable official sources. Figures and timelines that cannot be verified are always marked as practical estimates, and experience-based values are never presented as legal requirements.

GRZAN provides registration support in Kyrgyzstan for medical device manufacturers, importers and authorized representatives. For project consultation on Kyrgyzstan or Eurasian Economic Union market access, contact us at info@grzanglobal.com.

GRZAN | Global Medical Device Regulatory Registration and Compliance Services